{
    "Trade/Device Name(s)": [
        "Q.STEPS Biometer G/C Dual Monitoring System",
        "Q.STEPSim Biometer G/C Dual Monitoring System"
    ],
    "Submitter Information": "Biomedix, Inc., USA",
    "510(k) Number": "K050182",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033627",
        "K023558",
        "K031472"
    ],
    "Regulatory Class": "Class II; Class I",
    "Product Code(s)": [
        "CHH",
        "CGA",
        "NBW",
        "JIX"
    ],
    "Summary Letter Date": "August 9, 2005",
    "Summary Letter Received Date": "May 16, 2005",
    "Submission Date": "November 30, 2004",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1175"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Cholesterol test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Cholesterol"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Q.STEPS Biometer G/C"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic electrochemical biosensor"
    ],
    "Methodologies": [
        "Electrochemical detection",
        "Biosensor technology"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Q.STEPS Biometer G/C Dual Monitoring System for quantitative measurement of glucose and cholesterol in whole blood using enzymatic electrochemical biosensor technology",
    "Indications for Use Summary": "Intended for use by healthcare professionals and home users for quantitative measurement of glucose and cholesterol in whole blood from fingertips to aid in the management of carbohydrate metabolism disorders and disorders involving excess cholesterol or lipid metabolism.",
    "fda_folder": "Clinical Chemistry"
}